Back to results
US 11,149,244 B2Granted
Three-dimensional bioreactor for T-cell activation and expansion for immunotherapy
AssigneeSouthwest Research Institute
InventorJian Ling
Life of this patent
Estimating the term…
Abstract
The present invention relates to the application of a three-dimensional (3D) bioreactor for T-cell expansion for immunotherapy.
Claims21
A method for T-cell expansion comprising:
- supplying a 3D bioreactor of biocompatible polymeric material comprising a plurality of voids having a surface area for cell expansion, said plurality of voids having a diameter D, a plurality of pore openings between said voids having a diameter d, such that D>d and wherein:
- (a) 90% or more of said voids have a selected void volume (V) that does not vary by more than +/−10.0%;
- and (b) 90% or more of said pore openings between said voids have a value of d that does not vary by more than +/−10.0%;
- providing a polydopamine coating on said bioreactor surface area for cell expansion;
- providing a tetrameric protein attached to said polydopamine coating;
- providing one or more biotinylated antibodies immobilized on said tetrameric protein;
- flowing T-cells through said bioreactor having T-cell receptors where said T-cell receptors bind to said one or more biotinylated antibodies and are activated;
- exposing the activated T-cells to a perfusion media containing a signaling molecule to promote T-cell expansion.
5 more elements
Dependencies are inferred from the claim text.